Topics
Cardiovascular diseases
Remote monitoring of medical devices in Australia
The current industry-involved system may present a conflict of interest
Bradley Wilsmore · James Leitch
Cardiovascular disease in patients with schizophrenia
The physical health of patients with schizophrenia requires serious national attention
Leonard Kritharides · Vincent Chow · Tim JR Lambert
Overcoming cardiovascular disease in Indigenous Australians
Despite the profound impact of cardiovascular disease in Indigenous Australians, much remains to be achieved
Alex Brown · Leonard Kritharides
Encouraging early treatment of suspected heart attack: it’s OK to call 000
Making urgent decisions is complex: a campaign recognising this has succeeded in raising public awareness
Peter L Thompson · Trevor Shilton
Effect of a mass media campaign on ambulance use for chest pain
A well designed campaign can increase the use of emergency medical services
Ziad Nehme · Peter A Cameron · Muhammad Akram · Harry Patsamanis · Janet E Bray · Ian T Meredith · Karen Smith
Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia
n/a
Satvinder S Dhaliwal · Timothy A Welborn
Absolute risk of cardiovascular disease events and blood pressure- and lipid-lowering therapy in Australia
In reply
Emily Banks · Rosemary J Korda · Bill Stavreski
Lost in translation: the gap between what we know and what we do about cardiovascular disease
In reply
Clara K Chow · Anthony Rodgers
Acute coronary syndrome on Friday the 13th: a case for re-organising services?
Superstition and statistics: are some days better than others for heart attacks?
Majd B Protty · Mustafa Jaafar · Sahar Hannoodee · Phillip Freeman
Functional mitral valve regurgitation: repair or replacement?
Long term outcomes primarily depend on left ventricular function
Hugh D Wolfenden · Greg Cranney
New developments in coronary stent technology
Current performance standards are high and promising new technologies are finding it difficult to compete
Ahmad Farshid · Simon O'Connor
Update on pharmacotherapy for pulmonary hypertension
New pharmacological treatment options have improved the prognosis for those with this rare disease
David L Prior · Heath Adams · Trevor J Williams
Coronary stent technology: a narrative review
The ongoing quest for optimal efficacy without compromising long term patient safety
Daniel Chen · Nigel Jepson
The inequitable burden of group A streptococcal diseases in Indigenous Australians
We need to fill evidence gaps and make clinical advances to reduce these diseases of disadvantage
Philippa J May · Asha C Bowen · Jonathan R Carapetis
The jugular veins: gateway to the heart
Inspection of the jugular veins provides a simple means of determining whether pressures in the right side of the heart are normal or elevated
Andrew Elder · Balakrishnan (Kichu) R Nair
Disparities in acute in-hospital cardiovascular care for Aboriginal and non-Aboriginal South Australians
The lower rate of coronary angiography is the key disparity in the care of Aboriginal patients with acute coronary syndromes
Rosanna Tavella · Katharine McBride · Wendy Keech · Janet Kelly · Amanda Rischbieth · Christopher Zeitz · John F Beltrame · Philip A Tideman · Alex Brown
Progress in the care of familial hypercholesterolaemia: 2016
Significant advances have been made, but optimising models of care remains a major challenge
Damon A Bell · Gerald F Watts
General medicine Indigenous outreach registrar training in rural Queensland
n/a
Paul Jauncey · Scott McKenzie · Rohan Corpus · Kwun M Fong · Darren L Walters
Pitting and non-pitting oedema
The distinction is essential to determine aetiology and treatment
Elizabeth Whiting · Madeline E McCready
Time to bury “hypertension”
An absolute cardiovascular risk approach will better target patients who need pharmacotherapy
Mark R Nelson
“Congenital heart health”: how psychological care can make a difference
An integrated approach incorporating both physical and mental health is critical to “congenital heart health”
Nadine A Kasparian · David S Winlaw · Gary F Sholler
How health technology helps promote cardiovascular health outcomes
Health technology in the hands of cardiac patients — helpful, hindrance, or hesitate to say?
Robyn Gallagher · Lis Neubeck
Cardiac tamponade in undiagnosed systemic lupus erythematosus
A 22-year-old woman presented with a 3-day history of fever, retrosternal chest pain and exertional dyspnoea. Her heart rate was 130 bpm with a blood pressure level of 109/68 mmHg. Physical examination suggested tamponade: distended jugular veins, pulsus paradoxus and muffled heart tones. The chest radiography was notable for the characteristic water-bottle sign (Figure, A).1 Contrast-enhanced chest computed tomography demonstrated a massive pericardial effusion (Figure, B) associated with venous engorgement of the superior and inferior vena cava (SVC, IVC), prevascular space (arrows), and bilateral axillary veins (arrowheads). An emergency thoracoscopic pericardial window was performed and 620 mL of bloody fluid was drained. The presence of anti-nuclear, anti-double-stranded DNA, anti-Smith antibodies and hypocomplementaemia supported the diagnosis of systemic lupus erythematosus.2 The patient recovered after 1 week of intravenous methylprednisolone pulse therapy. At an 8-month follow-up, there have been no recurrences. Figure A B
Tsung-Han Ho · Yi-Tin Tsai
Improving outcomes in coronary artery disease
Systems, procedures and policies are needed to further reduce the toll of cardiovascular disease
Andrew I MacIsaac